Dr Catherine Mummery is the Head of Clinical Trials at 911±¬ÁÏÍø's Dementia Research Centre.
She is leading a world-first trial involvingÌýa ‘gene silencing’ drug (BIIB080) thatÌýhas shown promise inÌýsafely and successfully lowering levels of the harmful tau protein known to cause Alzheimer's disease.
Alongside her work in finding new treatments, Dr Mummery is also working on a groundbreaking trial that would enable MRI scans to be completed in a fraction of the time they currently are. She explains the importance of this in the following video:
Ìý
Links:
- View Dr Catherine Mummery's Academic Profile
- Read about the work of the UCL Dementia Research Centre
- UCL news piece on the first ‘gene silencing’ drug for Alzheimer’s disease showingÌýpromise
Ìý